On August 13, 2025, 180 Life Sciences Corp. entered into a Sales Agreement to sell up to $500 million of common stock through Clear Street LLC. The company also reported the exercise of warrants resulting in the issuance of 1,749 shares at $2.65 each and 100,000 shares at $2.28 each, bringing in additional cash.